期刊论文详细信息
| Letter by Robinson Regarding Articles, Bringing Back Targets to 'IMPROVE' Atherosclerotic Cardiovascular Disease Outcomes: The Duel for Dual Goals; Are Two Targets Better Than One? and Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT | |
| Letter | |
| DOI : 10.1161/CIRCULATIONAHA.115.019345 | |
| 来源: SCIE | |
【 授权许可】
Free